About Heartstitch GmbHHeartStitch® Inc. was founded by Prof. Anthony Nobles with the intent of leveraging its technologies in the structural heart marketplace. HeartStitch® is focused on innovative suture-based systems for remotely providing suture repair of structural heart defects and other vascular structures.
Founder and CEO: Anthony Nobles
CFO: Richard Bjorkman
6 articles with Heartstitch GmbH
HeartStitch® Presents Initial Clinical Results Of New Tricuspid Valve Repair At CSI Frankfurt Clinical Congresses
HeartStitch® Presented Initial Data For Its New Suture-based tricuspid valve repair and remodeling technique.
HeartStitch® has received its CE Mark in the European Union for its device for treatment of mitral valve repair.
HeartStitch®, Inc. Announces CE Mark for its Minimally Invasive Trans-Apical Access and Closure Device
Revolutionary New Heart Valve Repair -- Performed for The First Time In Patients -- Demonstrates Feasibility of New Suture Based Technique
HeartStitch®, Inc. And National Research Cardiac Surgery Center in Astana Announce Successful Clinical Test of Novel Tricuspid Valve Repair With Minimally Invasive HeartStitch® Suture Technique On Two Patients.
Kardia announced expansion plan of the NobleStitch EL at a recent meeting organized by Professor Francesco Romeo at Policlinico Tor Vergata in Rome where Prof. Achille Gaspardone performed a successful NobleStitch™ EL live case that was transmitted to the attendees in Ayla Magna, Rome, Italy.
Heartstitch GmbH Announces Noblestitch EL Closure Data Compared To Published PFO Clinical Trials "RESPECT" And "CLOSURE" In The New England Journal of Medicine